KA
HELP

Kovack Advisors’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Kovack Advisors’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-263
Closed -$2.71K – 598
2024
Q2 		$2.71K Hold
263
– – ﹤0.01% 572
2024
Q1 		$4.13K Hold
263
– – ﹤0.01% 472
2023
Q4 		$4.1K Hold
263
– – ﹤0.01% 572
2023
Q3 		$5.31K Buy
+263
New +$3.87K ﹤0.01% 550

Other funds holding HELP

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
PP
PDS Planning Dublin, Ohio $1.73B AUM 24.11% 1-Year Est. Return

Kovack Advisors's HELP Position: Q3 2024 in Review

Kovack Advisors sold out of Helus Pharma Inc. Common Stock (HELP) in Q3 2024, closing a stake of 263 shares — an estimated $2.71K sold.

Kovack Advisors first reported a position in HELP in Q3 2023 and held it in 4 quarters. The position peaked at $5.31K in Q3 2023. 46 funds tracked by Wall St. Rank hold HELP as of Q3 2024.

  • Kovack Advisors reported no remaining Helus Pharma Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Kovack Advisors sold 263 Helus Pharma Inc. Common Stock shares in Q3 2024, an estimated $2.71K.
  • Kovack Advisors first reported a position in Helus Pharma Inc. Common Stock in Q3 2023 and held it in 4 quarters.
  • Kovack Advisors's Helus Pharma Inc. Common Stock position peaked at $5.31K in Q3 2023.
  • 46 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q3 2024.

Based on Kovack Advisors's 13F filing for Q3 2024, filed 5 Nov 2024.